FDA news weighs on shares
Abbott is dropping sharply on FDA-related news that surfaced before the open, though the move is milder than the broader healthcare sector sell-off tracking the S&P lower.
Sources: https://www.ad-hoc-news.de/boerse/news/corporate-news/abbott-laboratories-stock-before-the-bell-falls-2-6-percent/70079995, https://www.ad-hoc-news.de/boerse/news/corporate-news/
Previous verdicts for ABT
- AI Search: Abbott Rallies on FDA Approval for CardioMEMS Upgrade — 2026-10-05
- ABT Earnings Call Dip — 2026-09-30
- ABT drifts lower quietly — 2026-09-24
- Bond Yields Crush Stocks — 2026-09-11
- Defensive Rotation Out — 2026-08-27
Sources
Ezbrisk weighs each event against the market reaction and publishes a verdict with an overreaction reading. How the methodology works